Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non–Small Cell Lung Cancer: Brief Report-Reference-Cited by-同舟云学术

Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non–Small Cell Lung Cancer: Brief Report

Published:2018-08 Issue:8 Volume:13 Page:1217-1221
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Owada-Ozaki Yuki,Muto Satoshi,Takagi Hironori,Inoue Takuya,Watanabe Yuzuru,Fukuhara Mitsuro,Yamaura Takumi,Okabe Naoyuki,Matsumura Yuki,Hasegawa Takeo,Ohsugi Jun,Hoshino Mika,Shio Yutaka,Nanamiya Hideaki,Imai Jun-ichi,Isogai Takao,Watanabe Shinya,Suzuki Hiroyuki

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference8 articles.

1. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016

2. Nivolumab plus ipilimumab as first-line treatment for advanced non–small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study;Hellmann;Lancet Oncol,2017

3. Nivolumab versus docetaxel in previously treated patients with advanced non–small-cell lung cancer: two-year outcomes from two randomized, open-label, phase iii trials (CheckMate 017 and CheckMate 057);Horn;J Clin Oncol,2017

4. First-line nivolumab in stage IV or Recurrent non–small-cell lung cancer;Carbone;N Engl J Med,2017

5. Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set;Roszik;BMC Med,2016

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-Cancer Analysis of GALNT6 with Potential Implications for Prognosis and Tumor Microenvironment in Human Cancer Based on Bioinformatics and qPCR Verification;International Journal of General Medicine;2024-05

2. Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected;Frontiers in Cellular and Infection Microbiology;2024-02-02

3. Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma;BMC Cancer;2024-01-17

4. Clinical, Genomic, and Transcriptomic Featurses of Lung Adenocarcinoma With Uncommon EGFR Mutation;Clinical Lung Cancer;2024-01

5. Research Progress of Radiotherapy Combined with Immunotherapy in Non-Small Cell Lung Cancer;Journal of Clinical Personalized Medicine;2024